Terrace Biotech 的(de)(de)(de)專(zhuan)業(ye)知(zhi)識(shi)源于 UCSF 醫學(xue)中心的(de)(de)(de)肺(fei)研(yan)(yan)究小(xiao)組，該小(xiao)組幫(bang)助表征(zheng)了肺(fei)表面活性物質(zhi)，然后開(kai)發(fa)了一種(zhong)合成形式(shi)，用(yong)(yong)于治(zhi)療(liao)患有呼吸窘迫綜合征(zheng)的(de)(de)(de)早產兒。Terrace Biotech 擁有超(chao)過 25 年的(de)(de)(de)肺(fei)細胞(bao)生物學(xue)研(yan)(yan)究經驗，將其專(zhuan)業(ye)知(zhi)識(shi)應用(yong)(yong)于醫學(xue)研(yan)(yan)究的(de)(de)(de)進一步創(chuang)新和改善人類健康。

Group at UCSF Medical Center that helped characterize pulmonary surfactant and then developed a synthetic form of it that is used to treat premature infants with respiratory distress syndrome. With over twenty-five years of 'hands on' research experience in lung cell biology, Terrace Biotech applies its expertise to further innovation in medical research and improve human health.

Terrace Biotech 生產特(te)異(yi)性(xing)(xing)針對(dui)人(ren)肺泡1型(xing)和(he)2型(xing)的胞(bao)的特(te)異(yi)性(xing)(xing)抗體。抗體被廣泛(fan)應(ying)用(yong)于：免(mian)疫(yi)組化、Western Blot,流(liu)式細胞(bao)分離，細胞(bao)分選等。靶點科技現貨庫存(cun)，歡(huan)迎訂購。背景知識介紹見(jian)靶點商城。

產品信息(xi)：